Drug Shortage Report for NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION

Last updated on 2024-08-30 History
Report ID 233218
Drug Identification Number 02501449
Brand name NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION
Common or Proper name Norepinephrine Bitartrate USP in 5% Dextrose
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) NOREPINEPHRINE
Strength(s) 0.032MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes CJPE7788 - 8mg (0.032 mg/mL) – 20 bags/case
ATC code C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2024-07-17
Actual start date 2024-07-17
Estimated end date 2024-08-31
Actual end date 2024-08-29
Shortage status Resolved
Updated date 2024-08-30
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2024-08-30 English Compare
v5 2024-08-29 French Compare
v4 2024-08-29 English Compare
v3 2024-07-18 English Compare
v2 2024-07-17 French Compare
v1 2024-07-17 English Compare

Showing 1 to 6 of 6